Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$40.7M
+37.6% from 2023
Prescriptions
1,096
$37,105.59 per claim
Patients
180
215 prescribers
Total spending, 2024
$40.7M
$225,931.79 per patient
Medicare prescription drug plans paid $40.7M for Vitrakvi in 2024, for 1,096 prescriptions and refills to 180 patients (up 37.6% from 2023). The average cost per claim was $37,105.59.
California had the highest Medicare cost for Vitrakvi in 2024: $8.4M for 225 claims, followed by Florida ($4.0M).
Lee S Schwartzberg, medical oncology in Reno, NV, had the highest Medicare cost for Vitrakvi in 2024: 29 claims costing $883K.
Vitrakvi is made by Bayer Aktiengesellschaft (BAYN.DE), listed in the Medicare spending data as Bayer Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Lee S Schwartzberg Reno, NV | Medical Oncology | 29 | Under 11 | $883K |
| Weber Chen Pasadena, CA | Hematology-Oncology | 19 | Under 11 | $642K |
| Francis P Worden |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 140 | 646 | 115 | $22.0M |
| 2023 | 178 | 804 | 144 | $29.5M |
| 2024 | 215 | 1,096 | 180 | $40.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 17 |
| Under 11 |
| $596K |
| Weijing Sun Westwood, KS | Medical Oncology | 14 | Under 11 | $557K |
| Hoa C Duong Sacramento, CA | Medical Oncology | 13 | Under 11 | $551K |
| Joseph I Clark Maywood, IL | Hematology-Oncology | 13 | Under 11 | $518K |
| Arun S Singh Santa Monica, CA | Hematology-Oncology | 13 | Under 11 | $516K |
| Jessica R Bauman Philadelphia, PA | Hematopoietic Cell Transplantation and Cellular Therapy | 13 | Under 11 | $514K |
| Hao Wang Boston, MA | Internal Medicine | 12 | Under 11 | $508K |
| Rachelle C Olsen Los Angeles, CA | Physician Assistant | 14 | Under 11 | $507K |
| Humberto J Caldera Lake Worth, FL | Hematology-Oncology | 13 | Under 11 | $503K |
| Daniel M Buroker Ankeny, IA | Medical Oncology | 13 | Under 11 | $496K |
| Leslie Klein Scottsdale, AZ | Hematology-Oncology | 13 | Under 11 | $494K |
| Elham Abbasi-Hafshejani The Woodlands, TX | Hematology-Oncology | 13 | Under 11 | $480K |
| Nayha Tahir San Francisco, CA | Internal Medicine | 12 | Under 11 | $478K |
| Jasmine E Gillett Los Angeles, CA | Physician Assistant | 12 | Under 11 | $477K |
| Anthony W Stephens Newburgh, IN | Hematology-Oncology | 12 | Under 11 | $476K |
| Gustavo L Fernandez-Castro New York, NY | Hematology-Oncology | 12 | Under 11 | $472K |
| Ahmed Al-Hazzouri Clermont, FL | Medical Oncology | 12 | Under 11 | $470K |
| Marcia S Brose Philadelphia, PA | Medical Oncology | 12 | Under 11 | $470K |
| Sridhar E Pal Charlotte, NC | Hematology-Oncology | 12 | Under 11 | $467K |
| Chelsea L Cramer Egg Harbor Township, NJ | Nurse Practitioner | 13 | Under 11 | $467K |
| Ashray Maniar Portland, OR | Hematology-Oncology | 11 | Under 11 | $466K |
| Nam Q Bui Stanford, CA | Internal Medicine | 12 | Under 11 | $465K |
| Susanna V Ulahannan Ponca City, OK | Medical Oncology | 11 | Under 11 | $448K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Bayer Inc. BAYN.DE | 1,096 | $40.7M |